Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Chemical & Material

>>

Bromhexine Market


Bromhexine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report code: SDMRCH1553372 | Industry: Chemical & Material | Published On: 1/6/2020


Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Bromhexine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Bromhexine market segmented into
Oral
Injection

Based on the end-use, the global Bromhexine market classified into
Chronic Bronchitis
Asthma
Others

Based on geography, the global Bromhexine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Sanofi Aventis
Teva
Boehringer Ingelheim
Novartis
Mylan
Sanyo Chemical Laboratroy
Sandoz
LGM Pharma
GSK
Mayne Pharma
Sigma-Aldrich
Abbott
Shanghai Sine Tianping Pharmaceutical
Takeda
Shanghai Xudong Haipu Pharmaceutical
Jincheng Haisi Pharmaceutical
Shanxi Powerdone Pharmaceutical
Shanxi Powerdone Pharmaceutical
Wanbangde Pharmaceutical Group
Shijiazhuang No.4 Pharmaceutical
Ma'AnShan BBCA Pharmaceutical

Table  of  Contents
1    RESEARCH  SCOPE
        1.1  Research  Product  Definition
        1.2  Research  Segmentation
                1.2.1  Product  Type
                1.2.2  Main  product  Type  of  Major  Players
        1.3  Demand  Overview
        1.4  Research  Methodology
2  GLOBAL  BROMHEXINE  INDUSTRY
        2.1  Summary  about  Bromhexine  Industry
        2.2  Bromhexine  Market  Trends
                2.2.1  Bromhexine  Production  &  Consumption  Trends
                2.2.2  Bromhexine  Demand  Structure  Trends
        2.3  Bromhexine  Cost  &  Price
3    MARKET  DYNAMICS
        3.1  Manufacturing  &  Purchasing  Behavior  in  2020
        3.2  Market  Development  under  the  Impact  of  COVID-19
                3.2.1  Drivers
                3.2.2  Restraints
                3.2.3  Opportunity
                3.2.4  Risk
4    GLOBAL  MARKET  SEGMENTATION
        4.1  Region  Segmentation  (2017  to  2021f)
                4.1.1  North  America  (U.S.,  Canada  and  Mexico)
                4.1.2  Europe  (Germany,  UK,  France,  Italy,  Rest  of  Europe)
                4.1.3  Asia-Pacific  (China,  India,  Japan,  South  Korea,  Southeast  Asia,  Australia,  Rest  of  Asia  Pacific)
                4.1.4  South  America  (Brazil,,  Argentina,  Rest  of  Latin  America)
                4.1.5  Middle  East  and  Africa  (GCC,  North  Africa,  South  Africa,  Rest  of  Middle  East  and  Africa)
        4.2  Product  Type  Segmentation  (2017  to  2021f)
                4.2.1  Oral
                4.2.2  Injection
        4.3  Consumption  Segmentation  (2017  to  2021f)
                4.3.1  Chronic  Bronchitis
                4.3.2  Asthma
                4.3.3  Others
5    NORTH  AMERICA  MARKET  SEGMENT
        5.1  Region  Segmentation  (2017  to  2021f)
                5.1.1  U.S.
                5.1.2  Canada
                5.1.3  Mexico
        5.2  Product  Type  Segmentation  (2017  to  2021f)
                5.2.1  Oral
                5.2.2  Injection
        5.3  Consumption  Segmentation  (2017  to  2021f)
                5.3.1  Chronic  Bronchitis
                5.3.2  Asthma
                5.3.3  Others
        5.4  Impact  of  COVID-19  in  North  America
6    EUROPE  MARKET  SEGMENTATION
        6.1  Region  Segmentation  (2017  to  2021f)
                6.1.1  Germany
                6.1.2  UK
                6.1.3  France
                6.1.4  Italy
                6.1.5  Rest  of  Europe
        6.2  Product  Type  Segmentation  (2017  to  2021f)
                6.2.1  Oral
                6.2.2  Injection
        6.3  Consumption  Segmentation  (2017  to  2021f)
                6.3.1  Chronic  Bronchitis
                6.3.2  Asthma
                6.3.3  Others
        6.4    Impact  of  COVID-19  in  Europe
7    ASIA-PACIFIC  MARKET  SEGMENTATION
        7.1  Region  Segmentation  (2017  to  2021f)
                7.1.1  China
                7.1.2  India
                7.1.3  Japan
                7.1.4  South  Korea
                7.1.5  Southeast  Asia
                7.1.6  Australia
                7.1.7  Rest  of  Asia  Pacific
        7.2  Product  Type  Segmentation  (2017  to  2021f)
                7.2.1  Oral
                7.2.2  Injection
        7.3  Consumption  Segmentation  (2017  to  2021f)
                7.3.1  Chronic  Bronchitis
                7.3.2  Asthma
                7.3.3  Others
        7.4    Impact  of  COVID-19  in  Europe
8    SOUTH  AMERICA  MARKET  SEGMENTATION
        8.1  Region  Segmentation  (2017  to  2021f)
                8.1.1  Brazil
                8.1.2  Argentina
                8.1.3  Rest  of  Latin  America
        8.2  Product  Type  Segmentation  (2017  to  2021f)
                8.2.1  Oral
                8.2.2  Injection
        8.3  Consumption  Segmentation  (2017  to  2021f)
                8.3.1  Chronic  Bronchitis
                8.3.2  Asthma
                8.3.3  Others
        8.4    Impact  of  COVID-19  in  Europe
9    MIDDLE  EAST  AND  AFRICA  MARKET  SEGMENTATION
        9.1  Region  Segmentation  (2017  to  2021f)
                9.1.1  GCC
                9.1.2  North  Africa
                9.1.3  South  Africa
                9.1.4  Rest  of  Middle  East  and  Africa
        9.2  Product  Type  Segmentation  (2017  to  2021f)
                9.2.1  Oral
                9.2.2  Injection
        9.3  Consumption  Segmentation  (2017  to  2021f)
                9.3.1  Chronic  Bronchitis
                9.3.2  Asthma
                9.3.3  Others
        9.4    Impact  of  COVID-19  in  Europe
10  COMPETITION  OF  MAJOR  PLAYERS
        10.1  Brief  Introduction  of  Major  Players
                10.1.1  Sanofi  Aventis
                10.1.2  Teva
                10.1.3  Boehringer  Ingelheim
                10.1.4  Novartis
                10.1.5  Mylan
                10.1.6  Sanyo  Chemical  Laboratroy
                10.1.7  Sandoz
                10.1.8  LGM  Pharma
                10.1.9  GSK
                10.1.10  Mayne  Pharma
                10.1.11  Sigma-Aldrich
                10.1.12  Abbott
                10.1.13  Shanghai  Sine  Tianping  Pharmaceutical
                10.1.14  Takeda
                10.1.15  Shanghai  Xudong  Haipu  Pharmaceutical
                10.1.16  Jincheng  Haisi  Pharmaceutical
                10.1.17  Shanxi  Powerdone  Pharmaceutical
                10.1.18  Shanxi  Powerdone  Pharmaceutical
                10.1.19  Wanbangde  Pharmaceutical  Group
                10.1.20  Shijiazhuang  No.4  Pharmaceutical
                10.1.21  Ma'AnShan  BBCA  Pharmaceutical
        10.2    Bromhexine  Sales  Date  of  Major  Players  (2017-2020e)
                10.2.1  Sanofi  Aventis
                10.2.2  Teva
                10.2.3  Boehringer  Ingelheim
                10.2.4  Novartis
                10.2.5  Mylan
                10.2.6  Sanyo  Chemical  Laboratroy
                10.2.7  Sandoz
                10.2.8  LGM  Pharma
                10.2.9  GSK
                10.2.10  Mayne  Pharma
                10.2.11  Sigma-Aldrich
                10.2.12  Abbott
                10.2.13  Shanghai  Sine  Tianping  Pharmaceutical
                10.2.14  Takeda
                10.2.15  Shanghai  Xudong  Haipu  Pharmaceutical
                10.2.16  Jincheng  Haisi  Pharmaceutical
                10.2.17  Shanxi  Powerdone  Pharmaceutical
                10.2.18  Shanxi  Powerdone  Pharmaceutical
                10.2.19  Wanbangde  Pharmaceutical  Group
                10.2.20  Shijiazhuang  No.4  Pharmaceutical
                10.2.21  Ma'AnShan  BBCA  Pharmaceutical
        10.3    Market  Distribution  of  Major  Players
        10.4  Global  Competition  Segmentation
11    MARKET  FORECAST
        11.1    Forecast  by  Region
        11.2    Forecast  by  Demand
        11.3    Environment  Forecast
                11.3.1    Impact  of  COVID-19
                11.3.2    Geopolitics  Overview
                11.3.3    Economic  Overview  of  Major  Countries
12    REPORT  SUMMARY  STATEMENT
List of Table
Table Bromhexine Product Type Overview
Table Bromhexine Product Type Market Share List
Table Bromhexine Product Type of Major Players
Table Brief Introduction of Sanofi Aventis
Table Brief Introduction of Teva
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of Novartis
Table Brief Introduction of Mylan
Table Brief Introduction of Sanyo Chemical Laboratroy
Table Brief Introduction of Sandoz
Table Brief Introduction of LGM Pharma
Table Brief Introduction of GSK
Table Brief Introduction of Mayne Pharma
Table Brief Introduction of Sigma-Aldrich
Table Brief Introduction of Abbott
Table Brief Introduction of Shanghai Sine Tianping Pharmaceutical
Table Brief Introduction of Takeda
Table Brief Introduction of Shanghai Xudong Haipu Pharmaceutical
Table Brief Introduction of Jincheng Haisi Pharmaceutical
Table Brief Introduction of Shanxi Powerdone Pharmaceutical
Table Brief Introduction of Shanxi Powerdone Pharmaceutical
Table Brief Introduction of Wanbangde Pharmaceutical Group
Table Brief Introduction of Shijiazhuang No.4 Pharmaceutical
Table Brief Introduction of Ma'AnShan BBCA Pharmaceutical
Table Products & Services of Sanofi Aventis
Table Products & Services of Teva
Table Products & Services of Boehringer Ingelheim
Table Products & Services of Novartis
Table Products & Services of Mylan
Table Products & Services of Sanyo Chemical Laboratroy
Table Products & Services of Sandoz
Table Products & Services of LGM Pharma
Table Products & Services of GSK
Table Products & Services of Mayne Pharma
Table Products & Services of Sigma-Aldrich
Table Products & Services of Abbott
Table Products & Services of Shanghai Sine Tianping Pharmaceutical
Table Products & Services of Takeda
Table Products & Services of Shanghai Xudong Haipu Pharmaceutical
Table Products & Services of Jincheng Haisi Pharmaceutical
Table Products & Services of Shanxi Powerdone Pharmaceutical
Table Products & Services of Shanxi Powerdone Pharmaceutical
Table Products & Services of Wanbangde Pharmaceutical Group
Table Products & Services of Shijiazhuang No.4 Pharmaceutical
Table Products & Services of Ma'AnShan BBCA Pharmaceutical
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Bromhexine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Bromhexine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Bromhexine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Bromhexine Market Forecast (Million USD) Share by Demand 2021f-2026f




List of Figure
Figure Global Bromhexine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bromhexine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bromhexine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bromhexine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bromhexine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Bromhexine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Bromhexine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Bronchitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Bronchitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Bronchitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Bronchitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Bronchitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Bronchitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bromhexine Sales Revenue (Million USD) of Sanofi Aventis 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Teva 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Mylan 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Sanyo Chemical Laboratroy 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Sandoz 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of LGM Pharma 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of GSK 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Mayne Pharma 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Sigma-Aldrich 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Abbott 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Shanghai Sine Tianping Pharmaceutical 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Takeda 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Shanghai Xudong Haipu Pharmaceutical 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Jincheng Haisi Pharmaceutical 2017-2020e
Figure Bromhexine Sales Revenue (Million USD) of Shanxi Powerdone Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Shanxi Powerdone Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Wanbangde Pharmaceutical Group 2017-2020e
Figure Sales Revenue (Million USD) of Shijiazhuang No.4 Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Ma'AnShan BBCA Pharmaceutical 2017-2020e
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT